The assay exhibits excellent selectivity for the HER2-positive breast cancer cell line SK-BR-3 with a concentration-dependent signal 12.5× higher than HER2-negative cells (MDA-MB-231) [95]. This evidence concerns the gene ERBB2 and breast carcinoma.